Security key
88165K101
Tevogen Bio Holdings Inc. - Common Stock, par value $0.0001 per share (TVGN)
CUSIP: 88165K101
Q2 2024 13F Holders as of 30 Jun 2024
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 3,698,099
- Total 13F value
- $2,674,095
- Share change
- -2,759,763
- SEC-reported price per share
- $0.72
- Number of holders
- 26
- Value change
- -$2,032,470
- Number of buys
- 22
- Number of sells
- 2
- Shares outstanding
- 6,213,680
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2024
Institutions
26
Top holders
10
TVGN full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Tevogen Bio Holdings Inc. SEC filings
Tevogen Bio Holdings Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 88165K101
Recent filing periods:
Ownership snapshot
Top reported holders of TVGN - Tevogen Bio Holdings Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Portland Global Advisors LLC
Disclosed value leader
Surendra K. Ajjarapu
Comparable rows
3/15
Latest evidence
31 Mar 2024
13F
3/4/5
Lead comparable stake: 93%
12 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Portland Global Advisors LLC leads the comparable SEC ownership view at 93%.
3 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Portland Global Advisors LLC's linked filing trail.
Comparable ownership
Top 3
Portland Global Advisors LLC
93%
HRT FINANCIAL LP
0.2%
JPMORGAN CHASE & CO
0%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Portland Global Advisors LLC |
13F
Company
|
93%
|
$21,682,706
5,782,209 shares
|
— | 31 Mar 2024 |
| HRT FINANCIAL LP |
13F
Company
|
0.2%
|
$45,000
12,278 shares
|
— | 31 Mar 2024 |
| JPMORGAN CHASE & CO |
13F
Company
|
0%
|
$112
30 shares
|
— | 31 Mar 2024 |
| Surendra K. Ajjarapu |
3/4/5
CEO and Chairman, Director, 10%+ Owner
|
—
mixed-class rows
|
$96,001,335
17,477,778 shares
mixed-class rows
|
— | 07 Jun 2023 |
| SSVK Associates, LLC |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$85,321,335
7,988,889 shares
|
— | 07 Jun 2023 |
| Semper Paratus Sponsor LLC |
3/4/5
10%+ Owner
|
—
class O/S missing
|
—
4,294,444 shares
|
— | 07 Jun 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
26
Shares
3,698,099
Rows available
26
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2024 vs Q4 2025 Across Filers
Q4 2025 holders
47
Q2 2024 holders
26
Holder diff
-21
| Investor | Q4 2025 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q4 2025 value | Q2 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend